Historical record - last NADAC effective date: 5/22/2024
Product Information
MEROPENEM IV 500 MG VIAL is a generic product labeled by Eugia US LLC, priced at $2.8678 per EA under NDC 55150020720. Its NADAC has been published 57 times since Apr 17, 2024.
FDA first approved this application on Mar 27, 2017. Its Orange Book therapeutic-equivalence code is AP.
Strength
500 mg/1
Manufacturer
Eugia US LLCNDC
55150020720
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
5/22/2024
Active Ingredients
MEROPENEMApproval Type
Generic (ANDA)
FDA Application
ANDA205835FDA Approved
3/27/2017
TE Code
AP
On Market Since
3/27/2017
Pharmacological Classes
Price Statistics
The NADAC for MEROPENEM IV 500 MG VIAL has been published 57 times since Apr 17, 2024, and over the history we have for it it has declined 23.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8678 per EA |
|---|---|
| All-time high | $3.7564 (May 15, 2024) |
| All-time low | $2.8678 (May 22, 2024) |
| Median price | $2.8678 |
| Average price | $2.9457 |
| Largest weekly change | -23.7% (May 22, 2024) |
| Weeks tracked | 57 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-23.7%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Meropenem market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penem Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEROPENEM IV 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MEROPENEM IV 500 MG VIAL, manufactured by Eugia US LLC, is $2.8678 per EA (NDC 55150020720), effective May 14, 2025.
How has the price of MEROPENEM IV 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for MEROPENEM IV 500 MG VIAL has declined 23.7%. It has been tracked across 57 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MEROPENEM IV 500 MG VIAL?
Since Apr 17, 2024, the NADAC for MEROPENEM IV 500 MG VIAL has ranged from a low of $2.8678 (May 22, 2024) to a high of $3.7564 (May 15, 2024), with a median of $2.8678 per EA.
Are there cheaper alternatives to MEROPENEM IV 500 MG VIAL?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEROPENEM IV 500 MG VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures MEROPENEM IV 500 MG VIAL?
MEROPENEM IV 500 MG VIAL (NDC 55150020720) is labeled by Eugia US LLC, and CMS classifies it as a generic product.